10 20 30 40 50 60 70 80 1JY9 - Header ----|----|----|----|----|----|----|----|----|----|----|----|----|----|----|----| Asymmetric Unit
HEADER DE NOVO PROTEIN 11-SEP-01 1JY9
TITLE MINIMIZED AVERAGE STRUCTURE OF DP-TT2
COMPND MOL_ID: 1; COMPND 2 MOLECULE: DP-TT2; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES
SOURCE MOL_ID: 1; SOURCE 2 SYNTHETIC: YES; SOURCE 3 OTHER_DETAILS: THE PEPTIDE WAS SYNTHESIZED BY SOLID PHASE SOURCE 4 PEPTIDE SYNTHESIS.
KEYWDS BETA-HAIRPIN, DE NOVO PROTEIN
EXPDTA SOLUTION NMR
AUTHOR H.E.STANGER,F.A.SYUD,J.F.ESPINOSA,I.GIRIAT,T.MUIR, AUTHOR 2 S.H.GELLMAN
REVDAT 3 24-FEB-09 1JY9 1 VERSN REVDAT 2 17-OCT-01 1JY9 1 JRNL REVDAT 1 19-SEP-01 1JY9 0
JRNL AUTH H.E.STANGER,F.A.SYUD,J.F.ESPINOSA,I.GIRIAT,T.MUIR, JRNL AUTH 2 S.H.GELLMAN JRNL TITL LENGTH-DEPENDENT STABILITY AND STRAND LENGTH JRNL TITL 2 LIMITS IN ANTIPARALLEL BETA -SHEET SECONDARY JRNL TITL 3 STRUCTURE. JRNL REF PROC.NATL.ACAD.SCI.USA V. 98 12015 2001 JRNL REFN ISSN 0027-8424 JRNL PMID 11593011 JRNL DOI 10.1073/PNAS.211536998
REMARK 1
REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE.
REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : DIANA 1.5 REMARK 3 AUTHORS : GUNTERT, MUMENTHALER, WUTHRICH REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL
REMARK 4 REMARK 4 1JY9 COMPLIES WITH FORMAT V. 3.15, 01-DEC-08
REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 12-SEP-01. REMARK 100 THE RCSB ID CODE IS RCSB014325.
REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 277 REMARK 210 PH : 3.8 REMARK 210 IONIC STRENGTH : NULL REMARK 210 PRESSURE : AMBIENT REMARK 210 SAMPLE CONTENTS : 1 MM PEPTIDE REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D NOESY REMARK 210 SPECTROMETER FIELD STRENGTH : 600 MHZ REMARK 210 SPECTROMETER MODEL : INOVA REMARK 210 SPECTROMETER MANUFACTURER : VARIAN REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : DIANA 1.5 REMARK 210 METHOD USED : NOE INTENSITIES WERE REMARK 210 QUALITATIVELY ASSIGNED TO BE REMARK 210 STRONG, MEDIUM, WEAK OR VERY REMARK 210 WEAK, AND ASSIGNED CONSTRAINTS REMARK 210 OF 3, 4, 5, AND 6 REMARK 210 RESPECTIVELY; A TOTAL OF 32 REMARK 210 RESTRAINTS WERE USED FOR DP- REMARK 210 TT2. RESTRAINTS WERE CHECKED REMARK 210 USING "DISTANCE CHECK" REMARK 210 FUNCTION WITHIN DYANA WHICH REMARK 210 SHOWED THERE WERE NO "LONELY" REMARK 210 OR POSSIBLY MISASSIGNED NOES REMARK 210 WHICH COULD UNDULY INFLUENCE REMARK 210 THE FINAL CONFORMATION. DYANA REMARK 210 WAS USED TO GENERATE 500 REMARK 210 RANDOM STRUCTURES, WHICH WERE REMARK 210 SUBSEQUENTLY ANNEALED. THE REMARK 210 BEST 10 STRUCTURES (FEWEST REMARK 210 RESTRAINT VIOLATIONS) WERE REMARK 210 SELECTED. THIS ENTRY CONTAINS REMARK 210 THE MINIMIZED AVERAGE REMARK 210 STRUCTURE. REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : NULL REMARK 210 CONFORMERS, NUMBER SUBMITTED : 1 REMARK 210 CONFORMERS, SELECTION CRITERIA : NULL REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : NULL REMARK 210 REMARK 210 REMARK: ROESY TO CHECK FOR SPIN DIFFUSION.
REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS.
REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 THR A 2 -43.06 -174.13 REMARK 500 LYS A 12 -91.40 -160.13 REMARK 500 LYS A 13 -177.41 179.80 REMARK 500 ILE A 14 147.94 -176.36 REMARK 500 THR A 17 37.29 -153.93 REMARK 500 REMARK 500 REMARK: NULL
REMARK 999 REMARK 999 SEQUENCE REMARK 999 RESIDUE 12 IN THE PEPTIDE IS ORNITHINE. REMARK 999 FOR MODELLING, LYSINE WAS USED IN PLACE REMARK 999 OF ORNITHINE FOR EASE OF CALCULATION.
DBREF 1JY9 A 1 20 PDB 1JY9 1JY9 1 20
SEQRES 1 A 20 THR THR THR THR ARG TYR VAL GLU VAL DPR GLY LYS LYS SEQRES 2 A 20 ILE LEU GLN THR THR THR THR
HET DPR A 10 14
HETNAM DPR D-PROLINE
FORMUL 1 DPR C5 H9 N O2
SHEET 1 A 2 TYR A 6 VAL A 7 0 SHEET 2 A 2 ILE A 14 LEU A 15 -1 O ILE A 14 N VAL A 7
LINK C VAL A 9 N DPR A 10 1555 1555 1.36 LINK C DPR A 10 N GLY A 11 1555 1555 1.32
CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 1.000000 0.000000 0.000000 0.00000
SCALE2 0.000000 1.000000 0.000000 0.00000
SCALE3 0.000000 0.000000 1.000000 0.00000